Employees Retirement System of Texas’s Denali Therapeutics DNLI Stock Holding History

Employees Retirement System of Texas’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Sell	44,340 -2,837	-6%	-$58.3K	0.01%	237
2026 Q1	$906K	Hold	47,177	–	–	0.01%	227
2025 Q4	$779K	Buy	47,177 +3,408	+8%	+$57.5K	0.01%	257
2025 Q3	$636K	Hold	43,769	–	–	0.01%	264
2025 Q2	$612K	Hold	43,769	–	–	0.01%	292
2025 Q1	$595K	Hold	43,769	–	–	0.01%	232
2024 Q4	$892K	Hold	43,769	–	–	0.01%	272
2024 Q3	$1.27M	Hold	43,769	–	–	0.01%	273
2024 Q2	$1.02M	Hold	43,769	–	–	0.01%	264
2024 Q1	$898K	Buy	43,769 +22,394	+105%	+$421K	0.01%	278
2023 Q4	$459K	Buy	+21,375	New	+$423K	0.01%	306

Other funds holding DNLI

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Employees Retirement System of Texas's DNLI Position: Q2 2026 in Review

Employees Retirement System of Texas reduced its Denali Therapeutics (DNLI) stake by 6% in Q2 2026, selling an estimated $58.3K and leaving 44,340 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #237.

Employees Retirement System of Texas first reported a position in DNLI in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.27M in Q3 2024. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

Employees Retirement System of Texas held 44,340 shares of Denali Therapeutics worth $1.14M as of Q2 2026.
Employees Retirement System of Texas sold 2,837 Denali Therapeutics shares in Q2 2026, an estimated $58.3K.
Denali Therapeutics made up 0.01% of Employees Retirement System of Texas's portfolio in Q2 2026, its #237 holding.
Employees Retirement System of Texas first reported a position in Denali Therapeutics in Q4 2023 and has held it in 11 quarters since.
Employees Retirement System of Texas's Denali Therapeutics position peaked at $1.27M in Q3 2024.
292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Employees Retirement System of Texas's 13F filing for Q2 2026, filed 14 Aug 2026.